Proof-of-Concept Randomized Trial of the Monoclonal Antibody GSK249320 Versus Placebo in Stroke Patients

BACKGROUND AND PURPOSE—: One class of poststroke restorative therapy focuses on promoting axon outgrowth by blocking myelin-based inhibitory proteins such as myelin-associated glycoprotein. The purpose of the current study was to extend preclinical and clinical findings of GSK249320, a humanized mon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Stroke
Main Authors: Cramer, Steven C., Enney, Lori A., Russell, Colleen K., Simeoni, Monica, Thompson, Thomas R.
Formato: Artigo
Idioma:Inglês
Publicado em: Lippincott Williams & Wilkins 2017
Assuntos:
Original Contributions
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5325241/
https://ncbi.nlm.nih.gov/pubmed/28228578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.116.014517
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados